Select Publications

Dr. Jason Karnes Research Summary : 


Karnes, J. H. (2018). Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know? Pharmacogenomics, 19(18), 1413-1422. doi:10.2217/pgs-2018-0147

 

Karnes JH, Shaffer CM, Cronin R, Bastarache L, Gaudieri S, James I, Pavlos R, Steiner H, Mosley JD, Mallal S, Denny JC, Phillips EJ, Roden DM. Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin-like receptors (KIR) types on heparin-induced thrombocytopenia (HIT). Pharmacotherapy. 2017 Jul 8. doi: 10.1002/phar.1983. [Epub ahead of print] PubMed PMID: 28688202.

 

Kaye JB, Schultz LE, Steiner HE, Kittles RA, Cavallari LH, Karnes JH. Warfarin Pharmacogenomics in Diverse Populations.Pharmacotherapy. 2017 Jul 3. doi: 10.1002/phar.1982. [Epub ahead of print] PubMed PMID: 28672100.